These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 19100477

  • 1. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 2. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 3. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344
    [Abstract] [Full Text] [Related]

  • 4. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A, Goto M, Zhang J, Bennet W, Groth CG, Korsgren O, Wennberg L.
    Transplantation; 2003 Apr 27; 75(8):1409-14. PubMed ID: 12717240
    [Abstract] [Full Text] [Related]

  • 6. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 27; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 7. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor J.
    Transplant Proc; 2007 Dec 27; 39(10):2992-6. PubMed ID: 18089307
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis and treatment of chronic allograft nephropathy with everolimus.
    Lutz J, Zou H, Liu S, Antus B, Heemann U.
    Transplantation; 2003 Aug 15; 76(3):508-15. PubMed ID: 12923436
    [Abstract] [Full Text] [Related]

  • 9. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
    Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V.
    Transplant Proc; 2008 Apr 15; 40(3):856-60. PubMed ID: 18455036
    [Abstract] [Full Text] [Related]

  • 10. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
    Sugito K, Inoue M, Ikeda T, Hagiwara N, Koshinaga T, Kusafuka T.
    Transplant Proc; 2007 Dec 15; 39(10):3432-5. PubMed ID: 18089399
    [Abstract] [Full Text] [Related]

  • 11. FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.
    Tedesco-Silva H, Lorber MI, Foster CE, Sollinger HW, Mendez R, Carvalho DB, Shapiro R, Rajagopalan PR, Mayer H, Slade J, Kahan BD, FTY720A2202 clinical study group.
    Clin Transplant; 2009 Dec 15; 23(5):589-99. PubMed ID: 19719728
    [Abstract] [Full Text] [Related]

  • 12. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G, Pally C, Beerli C, Burkhart C, Wieczorek G, Metzler B, Morris RE, Wagner J, Bruns C.
    Transpl Int; 2010 May 01; 23(5):543-52. PubMed ID: 20003043
    [Abstract] [Full Text] [Related]

  • 13. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec 01; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 14. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 15. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, Fujita T.
    Transplant Proc; 1996 Apr 01; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract] [Full Text] [Related]

  • 16. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U.
    Kidney Int; 2004 Sep 01; 66(3):1248-56. PubMed ID: 15327424
    [Abstract] [Full Text] [Related]

  • 17. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
    Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Kusafuka T, Fukuzawa M.
    Transplant Proc; 2006 Nov 01; 38(9):3058-60. PubMed ID: 17112899
    [Abstract] [Full Text] [Related]

  • 18. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 01; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 19. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T, Hoshino Y, Rahman F, Amano Y, Higashi H, Kataoka H, Ohtsuki M, Teshima K, Chiba K, Kakefuda T, Suzuki S.
    Transplant Proc; 1996 Apr 01; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract] [Full Text] [Related]

  • 20. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R.
    Transplant Proc; 2004 Mar 01; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.